Loading... Please wait...
App Store Download on the App Store Google Play GET IT ON Google Play

Matinas BioPharma Holdings, Inc. (MTNB) Financials

Currency in USD Disclaimer
Add to Alerts
Add to Watchlist
$0.17 $0.01 (4.24%)
$0.16
$0.17
$0.11
$0.89
Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $1.10 M $3.19 M $33,333.00 $158,333.00 $90,000.00 $119,750.00 $149,687.00 $0.00 $194,494.00 $0.00
Cost of Revenue $941,000.00 $16.68 M $781,491.00 $14.36 M $11.23 M $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $155,000.00 -$13.49 M -$748,158.00 -$14.20 M -$11.14 M $119,750.00 $149,687.00 $0.00 $194,494.00 $0.00
Gross Profit Ratio 0.14 -4.23 -22.44 -89.69 -123.83 1 1 0 1 0
Research and Development Expenses $14.49 M $16.68 M $14.58 M $14.36 M $11.24 M $6.79 M $9.01 M $3.95 M $5.29 M $5.18 M
General & Administrative Expenses $10.37 M $11.10 M $10.18 M $10.01 M $7.78 M $7.98 M $7.64 M $4.31 M $4.81 M $5.29 M
Selling & Marketing Expenses -$941,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $9.43 M $11.10 M $10.18 M $10.01 M $7.78 M $7.98 M $7.64 M $4.31 M $4.81 M $5.29 M
Other Expenses $340,000.00 -$16.68 M $122,870.00 $686,425.00 $541,000.00 $56,552.00 $22,032.00 -$16,505.00 $19,627.00 -$25,173.00
Operating Expenses $23.92 M $11.10 M $24.77 M $24.36 M $19.01 M $14.77 M $16.65 M $8.26 M $10.11 M $10.46 M
Cost And Expenses $24.86 M $27.78 M $24.77 M $24.36 M $19.01 M $14.77 M $16.65 M $8.26 M $10.11 M $10.46 M
Interest Income $0.00 $1,000.00 $3,000.00 $7,000.00 $11,700.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 -$3.59 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $941,000.00 -$3.49 M -$1.33 M -$1.07 M -$1.01 M $218,308.00 $100,605.00 $52,644.00 $43,502.00 $41,581.00
EBITDA -$22.83 M -$28.08 M -$26.06 M -$25.28 M -$19.93 M -$14.43 M -$17.04 M -$8.88 M -$10.62 M -$10.69 M
EBITDA Ratio -20.83 -8.81 -781.9 -159.66 -221.42 -120.49 -113.83 0 -54.63 0
Operating Income -$23.77 M -$24.59 M -$24.73 M -$24.21 M -$18.92 M -$14.65 M -$16.50 M -$8.26 M -$9.91 M -$10.46 M
Operating Income Ratio -21.68 -7.71 -742.05 -152.88 -210.23 -122.31 -110.25 0 -50.96 0
Total Other Income/Expenses Net $824,000.00 $3.59 M $1.45 M $1.76 M $1.55 M $56,552.00 $658,959.00 $658,396.00 $776,099.00 $243,954.00
Income Before Tax -$22.94 M -$21.00 M -$23.28 M -$22.45 M -$17.37 M -$14.59 M -$15.84 M -$7.60 M -$9.14 M -$10.22 M
Income Before Tax Ratio -20.93 -6.59 -698.51 -141.77 -193.03 -121.84 -105.84 0 -46.97 0
Income Tax Expense $0.00 -$7.98 M -$2.11 M -$1.85 M -$1.79 M -$506,920.00 -$356,956.00 -$674,901.00 -$756,472.00 -$269,127.00
Net Income -$22.94 M -$13.02 M -$21.17 M -$20.60 M -$15.59 M -$14.08 M -$15.49 M -$7.60 M -$9.14 M -$10.22 M
Net Income Ratio -20.93 -4.08 -635.21 -130.1 -173.17 -117.6 -103.46 0 -46.97 0
EPS -0.11 -0.06 -0.1 -0.1 -0.11 -0.14 -0.17 -0.13 -0.18 -0.32
EPS Diluted -0.11 -0.06 -0.1 -0.1 -0.11 -0.14 -0.17 -0.13 -0.18 -0.32
Weighted Average Shares Out $217.26 M $216.81 M $210.18 M $196.89 M $145.20 M $98.10 M $90.48 M $57.65 M $51.48 M $32.08 M
Weighted Average Shares Out Diluted $217.26 M $216.81 M $210.18 M $196.89 M $145.20 M $98.10 M $90.48 M $57.65 M $51.48 M $32.08 M
Link
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In

or
Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Sign Up With Email Address
or
Continue with Google Continue with Apple

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.